OSIVAX
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • CAREERS >
      • Analyste Business Development
      • Technicien R&D (H/F) Poste en CDD de 6 mois, basé à Lyon (69)
    • LEGAL MENTIONS

LEGAL MENTIONS

Website Editor

OSIVAX SAS
99, rue de Gerland
69007 LYON
France

Phone: +33.437.655.503
Fax: +33.474.261.578
Mail: contact@osivax.com

Head office: 
OSIVAX SAS
4 rue de Copenhague
75008 PARIS
France
RCS: PARIS B 829 604 750
Share capital: 58,356.00€

Publishing Director

Delphine GUYON-GELLIN, Chief Business Development Officer

Website Hosting

WEEBLY INC.
564, Pacific Avenue
Suite 250
SAN FRANCISCO CA 94133
United States
Phone: +1.415.375.3268
Fax: +1.413.375.3268
Website: 
www.weebly.com

No warranty and no liability

While OSIVAX SAS is making great efforts to include accurate and up-to-date information, we make no representations or warranties, express or implied, as to the accuracy or completeness of the information provided on this Website and disclaim any liability for the use of this site or any site linked to it. OSIVAX SAS may change this site at any time without notice but does not assume any responsibility to update it. All users agree that all access and use of this Website and on any Website linked to from this site and the content thereof is at their own risk. Neither OSIVAX SAS nor any other party involved in creating, producing or delivering this Website or on any Website linked to from this site shall be liable in any manner whatsoever for any direct, incidental, consequential, indirect or punitive damages arising out of your access, use or inability to use this Website or any Website linked to from this site, or any errors or omissions in the content thereof.

Forward-looking information

This page may contain forward-looking information. Such information is subject to a variety of significant uncertainties, including scientific, business, economic and financial factors, and therefore actual results may differ significantly from those presented.

Links

Links to third party pages are provided for convenience only. We do not express any opinion on the content of any third party pages and expressly disclaim any liability for all third party information and the use of it.

Intellectual Property

This website and its content (including its overall layout as well as any text, photographs, images, trademarks, logos, videos, or other elements of the website) are the property of OSIVAX SAS or have been licensed to OSIVAX SAS. Any reproduction, adaptation, translation, whether in full or in part, of this website is strictly prohibited unless prior and written consent of OSIVAX SAS. No hypertext link to the website or to any part thereof may be established without the prior written consent of OSIVAX SAS.

Personal data protection

Your personal data are collected and used for information and communication only. In accordance with the Data Protection Act of January 6, 1978 (loi n°78-17 du 6 janvier 1978 relative à l’Informatique et aux Libertés), you have access to your personal data and you may request modification to or deletion of such data by e-mail at contact@osivax.com or by mail to OSIVAX, 99 rue de Gerland, 69007 LYON, France.

Applicable Law

​The present and the use of this website is governed by the French laws.
Proudly powered by Weebly
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • CAREERS >
      • Analyste Business Development
      • Technicien R&D (H/F) Poste en CDD de 6 mois, basé à Lyon (69)
    • LEGAL MENTIONS